ARTICLE | Emerging Company Profile
Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline
Emerging Company Profile: $170M raise led by Lake Bleu gives Ji Li cash to hunt neurology, eye disorder assets
March 31, 2021 1:14 AM UTC
Updated on Apr 2, 2021 at 8:39 PM UTC
Cross-border company AffaMed now has more than $170 million in series B funding and the backing of Lake Bleu Capital to pair with its hiring of one of China’s most prominent dealmakers, Ji Li, as it seeks to build up its in-licensed pipeline of compounds for neurology and ophthalmology.
Lake Bleu led the round, which also saw participation from the company’s founding investor, CBC Group. ...
BCIQ Company Profiles